BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24095175)

  • 1. Dietary supplements and medical foods for osteopenia and osteoporosis.
    Morgan SL
    J Clin Densitom; 2013; 16(4):394-401. PubMed ID: 24095175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feeding Infants and Toddlers Study: do vitamin and mineral supplements contribute to nutrient adequacy or excess among US infants and toddlers?
    Briefel R; Hanson C; Fox MK; Novak T; Ziegler P
    J Am Diet Assoc; 2006 Jan; 106(1 Suppl 1):S52-65. PubMed ID: 16376630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I'm a 65 year old woman who was recently diagnosed with osteopenia. How is this similar to osteoporosis, and how is it treated?
    Duke Med Health News; 2008 Aug; 14(8):12. PubMed ID: 19123259
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs and other product choices.
    Hyman PM; Carvajal R
    Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional foods and dietary supplements: products at the interface between pharma and nutrition.
    Eussen SR; Verhagen H; Klungel OH; Garssen J; van Loveren H; van Kranen HJ; Rompelberg CJ
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S2-9. PubMed ID: 21816140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
    Clay PG; Voss LE; Williams C; Daume EC
    Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
    Bryant ML; Worthington MA; Parsons K
    Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopenia and osteoporosis in pediatric patients after stem cell transplant.
    Rodgers C; Monroe R
    J Pediatr Oncol Nurs; 2007; 24(4):184-9. PubMed ID: 17588890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.
    Noonan C; Patrick Noonan W
    Toxicology; 2006 Apr; 221(1):4-8. PubMed ID: 16497425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of osteoporosis in liver disease.
    Hay JE; Guichelaar MM
    Clin Liver Dis; 2005 Nov; 9(4):747-66, viii. PubMed ID: 16207574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and regulation of natural products used as foods and food ingredients.
    Abdel-Rahman A; Anyangwe N; Carlacci L; Casper S; Danam RP; Enongene E; Erives G; Fabricant D; Gudi R; Hilmas CJ; Hines F; Howard P; Levy D; Lin Y; Moore RJ; Pfeiler E; Thurmond TS; Turujman S; Walker NJ
    Toxicol Sci; 2011 Oct; 123(2):333-48. PubMed ID: 21821733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis.
    Murray TM
    CMAJ; 1996 Oct; 155(7):935-9. PubMed ID: 8837543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FDA, medical foods, and patents.
    Czap A
    Altern Med Rev; 2002 Oct; 7(5):367-8. PubMed ID: 12410621
    [No Abstract]   [Full Text] [Related]  

  • 19. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation.
    Jiang T
    Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.